July 24, 2025

Tooth Loss, Gum Disease Linked to Stomach Cancer

Using sibling comparisons and nationwide registries, researchers evaluate how inflammation and tooth count independently affect gastric cancer risk in adults across Sweden.

Conexiant

July 24, 2025

Single Cell Analysis: Beyond The Transcriptome

The future of single-cell analysis lies in multi-omics, analytical depth, real time live cell analysis, and global accessibility – not just more sequencing

The Analytical Scientist

July 24, 2025

Does Menopausal Hormone Therapy Increase the Risk of Death in Women With BRCA-Mutated Breast Cancer?

The risk of death does not appear to increase with the use of menopausal hormone therapy in women with early-onset, BRCA-mutated breast cancer who began hormone supplementation after diagnosis, based ...

The ASCO Post

July 23, 2025

Association of Type 2 Diabetes With Colorectal Cancer Risk and Survival by Tumor Immunity Status

In a German population–based, matched case-control study reported in the Journal of Clinical Oncology, Wankhede et al found that type 2 diabetes is associated with colorectal cancer (CRC) risk and sur...

The ASCO Post

July 23, 2025

Deep Cell Diving

A multimodal cell atlas created with self-supervised learning reveals how protein complexes form and function across spatial scales

The Analytical Scientist

July 22, 2025

Chinese Herbal Medicine for Improving Adjuvant Chemotherapy Completion in Patients With Colon Cancer

Guest Editor’s Note: Although guidelines recommend adjuvant combination chemotherapy for patients with stage II and III colon cancer who are at high risk of disease recurrence, fewer than 50% complete...

The ASCO Post

July 18, 2025

ADA Forsyth Friday: Researchers identify cellular protein that may help inhibit key oral microbe also associated with colorectal cancer

ADA Forsyth Institute scientists describe how host cells potentially fight back against the common oral bacterium Fusobacterium nucleatum.

ADA News

July 18, 2025

Can Use of Aprepitant During Chemotherapy Improve Triple-Negative Breast Cancer Outcomes?

A commonly used antiemetic may help to improve patient outcomes when given during chemotherapy treatment for women with early triple-negative breast cancer, study findings suggest.

The ASCO Post

July 17, 2025

Hormone Therapy Type Tied to Diverging Risks of Breast Cancer Before Age 55

Researchers found that unopposed estrogen therapy was linked to reduced young-onset breast cancer risk, while estrogen plus progestin therapy increased risk in certain subgroups.

Conexiant